Could a simple ear device ease fibromyalgia pain?

NCT ID NCT04777500

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a safe electrical stimulation device placed on the ear (taVNS) can relieve chronic pain in people with fibromyalgia. Sixty participants will use the device twice daily for four weeks. Researchers will measure changes in pain, mood, and daily function to see if this approach helps.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

transcutaneous auricular vagus nerve stimulation (taVNS) device

What this could lead to

If it works, this could offer a non-drug, at-home option to reduce chronic pain and improve daily function for people with fibromyalgia.

What could go wrong

This is a small, early-stage study with no control group comparison yet. The device may not provide meaningful pain relief, and results may not apply to everyone with fibromyalgia.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FIBROMYALGIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

fibromyalgia Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Massachusetts General Hospital

    Charlestown, Massachusetts, 02129-2020, United States

    Contact Email: •••••@•••••

    Contact Email: •••••@•••••